Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
4.050
-0.200 (-4.71%)
At close: Dec 5, 2025, 4:00 PM EST
4.000
-0.050 (-1.23%)
After-hours: Dec 5, 2025, 5:11 PM EST
LIXT Market Cap
LIXT has a market cap or net worth of $23.10 million as of December 5, 2025. Its market cap has increased by 579.47% in one year.
Market Cap
23.10M
Enterprise Value
20.21M
1-Year Change
579.47%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $23.10M, a decrease of -51.26%. That is a compound annual growth rate of -13.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 23.10M | 402.17% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |